These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
335 related articles for article (PubMed ID: 8099807)
1. Examination by laser scanning confocal fluorescence imaging microscopy of the subcellular localisation of anthracyclines in parent and multidrug resistant cell lines. Coley HM; Amos WB; Twentyman PR; Workman P Br J Cancer; 1993 Jun; 67(6):1316-23. PubMed ID: 8099807 [TBL] [Abstract][Full Text] [Related]
2. Retention of activity by selected anthracyclines in a multidrug resistant human large cell lung carcinoma line without P-glycoprotein hyperexpression. Coley HM; Workman P; Twentyman PR Br J Cancer; 1991 Mar; 63(3):351-7. PubMed ID: 1672252 [TBL] [Abstract][Full Text] [Related]
3. The efflux of anthracyclines in multidrug-resistant cell lines. Coley HM; Twentyman PR; Workman P Biochem Pharmacol; 1993 Oct; 46(8):1317-26. PubMed ID: 7902089 [TBL] [Abstract][Full Text] [Related]
4. Modification by brefeldin A, bafilomycin A1 and 7-chloro-4-nitrobenz-2-oxa-1,3-diazole (NBD) of cellular accumulation and intracellular distribution of anthracyclines in the non-P-glycoprotein-mediated multidrug-resistant cell line COR-L23/R. Rhodes T; Barrand MA; Twentyman PR Br J Cancer; 1994 Jul; 70(1):60-6. PubMed ID: 7912544 [TBL] [Abstract][Full Text] [Related]
5. Changes in subcellular doxorubicin distribution and cellular accumulation alone can largely account for doxorubicin resistance in SW-1573 lung cancer and MCF-7 breast cancer multidrug resistant tumour cells. Schuurhuis GJ; van Heijningen TH; Cervantes A; Pinedo HM; de Lange JH; Keizer HG; Broxterman HJ; Baak JP; Lankelma J Br J Cancer; 1993 Nov; 68(5):898-908. PubMed ID: 8105865 [TBL] [Abstract][Full Text] [Related]
6. Further examination of 9-alkyl- and sugar-modified anthracyclines in the circumvention of multidrug resistance. Coley HM; Twentyman PR; Workman P Anticancer Drug Des; 1992 Dec; 7(6):471-81. PubMed ID: 1337431 [TBL] [Abstract][Full Text] [Related]
7. Improved cellular accumulation is characteristic of anthracyclines which retain high activity in multidrug resistant cell lines, alone or in combination with verapamil or cyclosporin A. Coley HM; Twentyman PR; Workman P Biochem Pharmacol; 1989 Dec; 38(24):4467-75. PubMed ID: 2604747 [TBL] [Abstract][Full Text] [Related]
8. A comparison of rhodamine 123 accumulation and efflux in cells with P-glycoprotein-mediated and MRP-associated multidrug resistance phenotypes. Twentyman PR; Rhodes T; Rayner S Eur J Cancer; 1994; 30A(9):1360-9. PubMed ID: 7999426 [TBL] [Abstract][Full Text] [Related]
9. 9-Alkyl, morpholinyl anthracyclines in the circumvention of multidrug resistance. Coley HM; Twentyman PR; Workman P Eur J Cancer; 1990; 26(6):665-7. PubMed ID: 1975502 [TBL] [Abstract][Full Text] [Related]
10. Differential recognition of mdr1a and mdr1b gene products in multidrug resistant mouse tumour cell lines by different monoclonal antibodies. Barrand MA; Twentyman PR Br J Cancer; 1992 Feb; 65(2):239-45. PubMed ID: 1346747 [TBL] [Abstract][Full Text] [Related]
11. The novel anthracycline annamycin is not affected by P-glycoprotein-related multidrug resistance: comparison with idarubicin and doxorubicin in HL-60 leukemia cell lines. Consoli U; Priebe W; Ling YH; Mahadevia R; Griffin M; Zhao S; Perez-Soler R; Andreeff M Blood; 1996 Jul; 88(2):633-44. PubMed ID: 8695811 [TBL] [Abstract][Full Text] [Related]
12. Chemosensitisation and drug accumulation effects of cyclosporin A, PSC-833 and verapamil in human MDR large cell lung cancer cells expressing a 190k membrane protein distinct from P-glycoprotein. Barrand MA; Rhodes T; Center MS; Twentyman PR Eur J Cancer; 1993; 29A(3):408-15. PubMed ID: 8398342 [TBL] [Abstract][Full Text] [Related]
13. Laser scanning and confocal microscopy of daunorubicin, doxorubicin, and rhodamine 123 in multidrug-resistant cells. Weaver JL; Pine PS; Aszalos A; Schoenlein PV; Currier SJ; Padmanabhan R; Gottesman MM Exp Cell Res; 1991 Oct; 196(2):323-9. PubMed ID: 1680064 [TBL] [Abstract][Full Text] [Related]
14. Chemical synthesis and biological properties of novel fluorescent antifolates in Pgp- and MRP-overexpressing tumour cell lines. Robson C; Wright KA; Twentyman PR; Lambert PA; Griffin RJ Biochem Pharmacol; 1998 Oct; 56(7):807-16. PubMed ID: 9774142 [TBL] [Abstract][Full Text] [Related]
15. Ascorbic acid increases drug accumulation and reverses vincristine resistance of human non-small-cell lung-cancer cells. Chiang CD; Song EJ; Yang VC; Chao CC Biochem J; 1994 Aug; 301 ( Pt 3)(Pt 3):759-64. PubMed ID: 7914401 [TBL] [Abstract][Full Text] [Related]
16. Identification of anthracyclines and related agents that retain preferential activity over adriamycin in multidrug-resistant cell lines, and further resistance modification by verapamil and cyclosporin A. Coley HM; Twentyman PR; Workman P Cancer Chemother Pharmacol; 1989; 24(5):284-90. PubMed ID: 2547527 [TBL] [Abstract][Full Text] [Related]
17. Doxorubicin distribution in multicellular prostate cancer spheroids evaluated by confocal laser scanning microscopy and the "optical probe technique". Wartenberg M; Hescheler J; Acker H; Diedershagen H; Sauer H Cytometry; 1998 Feb; 31(2):137-45. PubMed ID: 9482283 [TBL] [Abstract][Full Text] [Related]
18. [Effect of quinine on the multiple drug resistance and intracellular distribution of pirarubicin in LR73 tumor cells: a comparative study with verapamil and S9788 by confocal laser microspectrofluorometry]. Belhoussine R; Morjani H; Manfait M Bull Cancer; 1997 Apr; 84(4):343-9. PubMed ID: 9238156 [TBL] [Abstract][Full Text] [Related]
19. Doxorubicin selected multidrug-resistant small cell lung cancer cell lines characterised by elevated cytoplasmic Ca2+ and resistance modulation by verapamil in absence of P-glycoprotein overexpression. Nygren P; Larsson R; Gruber A; Peterson C; Bergh J Br J Cancer; 1991 Dec; 64(6):1011-8. PubMed ID: 1684906 [TBL] [Abstract][Full Text] [Related]
20. Characterisation of a mouse tumour cell line with in vitro derived resistance to verapamil. Twentyman PR; Wright KA; Fox NE Br J Cancer; 1990 Feb; 61(2):279-84. PubMed ID: 1968761 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]